Evi Kostenis

发表

Class A Orphans (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

Helen E. Benson, Michael Spedding, Richard R. Neubig, 2020 .

Allosteric effect on muscarinic M2-receptors of derivatives of the alkane-bis-ammonium compound W84: comparison with bispyridinium-type allosteric modulators

Evi Kostenis, Ulrike Holzgrabe, U. Holzgrabe, 1994 .

Techniques: promiscuous Galpha proteins in basic research and drug discovery.

Graeme Milligan, Evi Kostenis, Magali Waelbroeck, 2005, Trends in pharmacological sciences.

A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands.

Evi Kostenis, E. Kostenis, 2004, Pharmacology & therapeutics.

Techniques: promiscuous Galpha proteins in basic research and drug discovery.

Graeme Milligan, Evi Kostenis, G. Milligan, 2005, Trends in pharmacological sciences.

Fluid Shear Stress Differentially Regulates gpr3, gpr6, and gpr12 Expression in Human Umbilical Vein Endothelial Cells

Evi Kostenis, E. Kostenis, A. Ardati, 2003, Cellular Physiology and Biochemistry.

P79 dependence of the potency of bisquaternary allosteric modulators of M2-cholinoceptors on the length of the central alkyl chain

Evi Kostenis, Ulrike Holzgrabe, Klaus Mohr, 1994 .

A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers.

Jamie Fong, Evi Kostenis, Shiv k. Sharma, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Decoding Signaling and Function of the Orphan G Protein–Coupled Receptor GPR17 with a Small-Molecule Agonist

Daniel Schulz, Evi Kostenis, Michel Gillard, 2013, Science Signaling.

A biased ligand for OXE-R uncouples Gα and Gβγ signaling within a heterotrimer.

Leonardo Pardo, Evi Kostenis, Michael Gütschow, 2012, Nature chemical biology.

Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.

Gerhard Wolber, Evi Kostenis, Marcel Bermudez, 2014, Journal of medicinal chemistry.

Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.

Evi Kostenis, Thomas M Frimurer, Trond Ulven, 2006, Journal of medicinal chemistry.

An optical dynamic mass redistribution assay reveals biased signaling of dualsteric GPCR activators

Evi Kostenis, E. Kostenis, K. Mohr, 2009, Journal of receptor and signal transduction research.

Sphingosine 1-phosphate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors.

Evi Kostenis, E. Kostenis, Kirsten Uhlenbrock, 2002, Cellular signalling.

Conjugated Linoleic Acids Mediate Insulin Release through Islet G Protein-coupled Receptor FFA1/GPR40*

Evi Kostenis, Trond Ulven, Manuel Grundmann, 2011, The Journal of Biological Chemistry.

Novel clusters of receptors for sphingosine‐1‐phosphate, sphingosylphosphorylcholine, and (lyso)‐phosphatidic acid: New receptors for “Old” ligands

Evi Kostenis, E. Kostenis, 2004, Journal of cellular biochemistry.

A physicogenetic method to assign ligand-binding relationships between 7TM receptors.

Evi Kostenis, Thomas M Frimurer, Trond Ulven, 2005, Bioorganic & medicinal chemistry letters.

Novel CRTH2 antagonists: a review of patents from 2006 to 2009

Evi Kostenis, Trond Ulven, E. Kostenis, 2010, Expert opinion on therapeutic patents.